サマリー

幹細胞治療の世界市場 2023-2027
幹細胞治療市場は、2022-2027年に1億1,659.09億米ドルの成長が予測され、予測期間中のCAGRは15.93%で加速すると予測されています。この調査レポートは、幹細胞治療市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、慢性疾患の増加、幹細胞治療に対する認知度の向上、医薬品開発に対する規制当局の認可の高まりによって牽引されています。
Technavioの幹細胞治療市場は以下のようにセグメント化されています：
用途別
- 癌
- 筋骨格系疾患
- 心血管疾患
- その他
タイプ別
- 同種移植
- 自家移植
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間の幹細胞治療市場の成長を牽引する主な要因の一つとして、幹細胞移植にかかる費用の上昇を挙げている。また、幹細胞療法は慢性疾患の潜在的な治療法であり、IPS細胞の開発は市場の大きな需要につながる。
本レポートでは、幹細胞治療市場について以下の分野をカバーしています：
- 幹細胞治療の市場規模
- 幹細胞治療市場の予測
- 幹細胞治療市場の産業分析
強固なベンダー分析は、クライアントが市場での地位を向上させるのに役立つよう設計されており、これに沿って、本レポートでは、Athersys Inc.、Becton Dickinson and Co、CRISPR Therapeutics AG、Cynata Therapeutics Ltd.、Cytori Therapeutics Inc.、富士フイルム株式会社、Gamida Cell Ltd.、ジョンソン・アンド・ジョンソン、Lonza Group Ltd.、Mesoblast Ltd.、Novartis AG、Pfizer Inc.、Pluristem Therapeutics Inc.、ReNeuron Group plc、STEMCELL Technologies Inc.、武田薬品工業株式会社、Thermo Fisher Scientific Inc.Ltd.、Thermo Fisher Scientific Inc.、Vericel Corp.また、幹細胞治療市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/stem-cell-therapy-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global stem cell therapy market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global stem cell therapy market 2017 - 2021 ($ million)
o 4.2 Application Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Cancer - Market size and forecast 2022-2027
o Exhibit 34: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
o 6.4 Musculoskeletal disorder - Market size and forecast 2022-2027
o Exhibit 38: Chart on Musculoskeletal disorder - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Musculoskeletal disorder - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Musculoskeletal disorder - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Musculoskeletal disorder - Year-over-year growth 2022-2027 (%)
o 6.5 Cardiovascular disease - Market size and forecast 2022-2027
o Exhibit 42: Chart on Cardiovascular disease - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Cardiovascular disease - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Cardiovascular disease - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Cardiovascular disease - Year-over-year growth 2022-2027 (%)
o 6.6 Others - Market size and forecast 2022-2027
o Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Application
o Exhibit 50: Market opportunity by Application ($ million)
o Exhibit 51: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 52: Chart on Type - Market share 2022-2027 (%)
o Exhibit 53: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 54: Chart on Comparison by Type
o Exhibit 55: Data Table on Comparison by Type
o 7.3 Allogeneic transplants - Market size and forecast 2022-2027
o Exhibit 56: Chart on Allogeneic transplants - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Allogeneic transplants - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Allogeneic transplants - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Allogeneic transplants - Year-over-year growth 2022-2027 (%)
o 7.4 Autologous transplants - Market size and forecast 2022-2027
o Exhibit 60: Chart on Autologous transplants - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Autologous transplants - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Autologous transplants - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Autologous transplants - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 64: Market opportunity by Type ($ million)
o Exhibit 65: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share by geography 2022-2027 (%)
o Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 107: Market opportunity by geography ($ million)
o Exhibit 108: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Athersys Inc.
o Exhibit 115: Athersys Inc. - Overview
o Exhibit 116: Athersys Inc. - Product / Service
o Exhibit 117: Athersys Inc. - Key offerings
o 12.4 Bristol Myers Squibb Co.
o Exhibit 118: Bristol Myers Squibb Co. - Overview
o Exhibit 119: Bristol Myers Squibb Co. - Product / Service
o Exhibit 120: Bristol Myers Squibb Co. - Key news
o Exhibit 121: Bristol Myers Squibb Co. - Key offerings
o 12.5 CRISPR Therapeutics AG
o Exhibit 122: CRISPR Therapeutics AG - Overview
o Exhibit 123: CRISPR Therapeutics AG - Product / Service
o Exhibit 124: CRISPR Therapeutics AG - Key offerings
o 12.6 Cynata Therapeutics Ltd.
o Exhibit 125: Cynata Therapeutics Ltd. - Overview
o Exhibit 126: Cynata Therapeutics Ltd. - Product / Service
o Exhibit 127: Cynata Therapeutics Ltd. - Key offerings
o 12.7 FUJIFILM Corp.
o Exhibit 128: FUJIFILM Corp. - Overview
o Exhibit 129: FUJIFILM Corp. - Business segments
o Exhibit 130: FUJIFILM Corp. - Key news
o Exhibit 131: FUJIFILM Corp. - Key offerings
o Exhibit 132: FUJIFILM Corp. - Segment focus
o 12.8 Gamida Cell Ltd.
o Exhibit 133: Gamida Cell Ltd. - Overview
o Exhibit 134: Gamida Cell Ltd. - Product / Service
o Exhibit 135: Gamida Cell Ltd. - Key offerings
o 12.9 Johnson and Johnson
o Exhibit 136: Johnson and Johnson - Overview
o Exhibit 137: Johnson and Johnson - Business segments
o Exhibit 138: Johnson and Johnson - Key news
o Exhibit 139: Johnson and Johnson - Key offerings
o Exhibit 140: Johnson and Johnson - Segment focus
o 12.10 Lonza Group Ltd.
o Exhibit 141: Lonza Group Ltd. - Overview
o Exhibit 142: Lonza Group Ltd. - Business segments
o Exhibit 143: Lonza Group Ltd. - Key news
o Exhibit 144: Lonza Group Ltd. - Key offerings
o Exhibit 145: Lonza Group Ltd. - Segment focus
o 12.11 Mesoblast Ltd.
o Exhibit 146: Mesoblast Ltd. - Overview
o Exhibit 147: Mesoblast Ltd. - Product / Service
o Exhibit 148: Mesoblast Ltd. - Key offerings
o 12.12 Novartis AG
o Exhibit 149: Novartis AG - Overview
o Exhibit 150: Novartis AG - Business segments
o Exhibit 151: Novartis AG - Key offerings
o Exhibit 152: Novartis AG - Segment focus
o 12.13 Pfizer Inc.
o Exhibit 153: Pfizer Inc. - Overview
o Exhibit 154: Pfizer Inc. - Product / Service
o Exhibit 155: Pfizer Inc. - Key news
o Exhibit 156: Pfizer Inc. - Key offerings
o 12.14 Pluristem Therapeutics Inc.
o Exhibit 157: Pluristem Therapeutics Inc. - Overview
o Exhibit 158: Pluristem Therapeutics Inc. - Product / Service
o Exhibit 159: Pluristem Therapeutics Inc. - Key offerings
o 12.15 ReNeuron Group plc
o Exhibit 160: ReNeuron Group plc - Overview
o Exhibit 161: ReNeuron Group plc - Product / Service
o Exhibit 162: ReNeuron Group plc - Key offerings
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 163: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 164: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 165: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.17 Vericel Corp.
o Exhibit 167: Vericel Corp. - Overview
o Exhibit 168: Vericel Corp. - Product / Service
o Exhibit 169: Vericel Corp. - Key news
o Exhibit 170: Vericel Corp. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 171: Inclusions checklist
o Exhibit 172: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 173: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 174: Research methodology
o Exhibit 175: Validation techniques employed for market sizing
o Exhibit 176: Information sources
o 13.5 List of abbreviations
o Exhibit 177: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global stem cell therapy market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Musculoskeletal disorder - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Musculoskeletal disorder - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Musculoskeletal disorder - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Musculoskeletal disorder - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Cardiovascular disease - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Cardiovascular disease - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Cardiovascular disease - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Cardiovascular disease - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Application ($ million)
Exhibits51: Data Table on Market opportunity by Application ($ million)
Exhibits52: Chart on Type - Market share 2022-2027 (%)
Exhibits53: Data Table on Type - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by Type
Exhibits55: Data Table on Comparison by Type
Exhibits56: Chart on Allogeneic transplants - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Allogeneic transplants - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Allogeneic transplants - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Allogeneic transplants - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Autologous transplants - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Autologous transplants - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Autologous transplants - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Autologous transplants - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Type ($ million)
Exhibits65: Data Table on Market opportunity by Type ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2022-2027 (%)
Exhibits68: Data Table on Market share by geography 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity by geography ($ million)
Exhibits108: Data Tables on Market opportunity by geography ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Athersys Inc. - Overview
Exhibits116: Athersys Inc. - Product / Service
Exhibits117: Athersys Inc. - Key offerings
Exhibits118: Bristol Myers Squibb Co. - Overview
Exhibits119: Bristol Myers Squibb Co. - Product / Service
Exhibits120: Bristol Myers Squibb Co. - Key news
Exhibits121: Bristol Myers Squibb Co. - Key offerings
Exhibits122: CRISPR Therapeutics AG - Overview
Exhibits123: CRISPR Therapeutics AG - Product / Service
Exhibits124: CRISPR Therapeutics AG - Key offerings
Exhibits125: Cynata Therapeutics Ltd. - Overview
Exhibits126: Cynata Therapeutics Ltd. - Product / Service
Exhibits127: Cynata Therapeutics Ltd. - Key offerings
Exhibits128: FUJIFILM Corp. - Overview
Exhibits129: FUJIFILM Corp. - Business segments
Exhibits130: FUJIFILM Corp. - Key news
Exhibits131: FUJIFILM Corp. - Key offerings
Exhibits132: FUJIFILM Corp. - Segment focus
Exhibits133: Gamida Cell Ltd. - Overview
Exhibits134: Gamida Cell Ltd. - Product / Service
Exhibits135: Gamida Cell Ltd. - Key offerings
Exhibits136: Johnson and Johnson - Overview
Exhibits137: Johnson and Johnson - Business segments
Exhibits138: Johnson and Johnson - Key news
Exhibits139: Johnson and Johnson - Key offerings
Exhibits140: Johnson and Johnson - Segment focus
Exhibits141: Lonza Group Ltd. - Overview
Exhibits142: Lonza Group Ltd. - Business segments
Exhibits143: Lonza Group Ltd. - Key news
Exhibits144: Lonza Group Ltd. - Key offerings
Exhibits145: Lonza Group Ltd. - Segment focus
Exhibits146: Mesoblast Ltd. - Overview
Exhibits147: Mesoblast Ltd. - Product / Service
Exhibits148: Mesoblast Ltd. - Key offerings
Exhibits149: Novartis AG - Overview
Exhibits150: Novartis AG - Business segments
Exhibits151: Novartis AG - Key offerings
Exhibits152: Novartis AG - Segment focus
Exhibits153: Pfizer Inc. - Overview
Exhibits154: Pfizer Inc. - Product / Service
Exhibits155: Pfizer Inc. - Key news
Exhibits156: Pfizer Inc. - Key offerings
Exhibits157: Pluristem Therapeutics Inc. - Overview
Exhibits158: Pluristem Therapeutics Inc. - Product / Service
Exhibits159: Pluristem Therapeutics Inc. - Key offerings
Exhibits160: ReNeuron Group plc - Overview
Exhibits161: ReNeuron Group plc - Product / Service
Exhibits162: ReNeuron Group plc - Key offerings
Exhibits163: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits164: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits165: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits166: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits167: Vericel Corp. - Overview
Exhibits168: Vericel Corp. - Product / Service
Exhibits169: Vericel Corp. - Key news
Exhibits170: Vericel Corp. - Key offerings
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations